Tandem Diabetes is driving transformative innovation to help reduce the burden of diabetes and create new possibilities for ...

DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, in ...

Retta reveals the first symptoms of her Type 2 diabetes. The actor shares the lifestyle changes she made and the glucose ...

Little did I realize a few grapes could send my blood sugar soaring until I tried the first glucose monitor without a ...

Wells Fargo analyst Larry Biegelsen maintained a Buy rating on Dexcom (DXCM – Research Report) yesterday and set a price target of ...

Shares of DexCom Inc. DXCM slid 2.07% to $70.43 Friday, on what proved to be an all-around mixed trading session for the ...

For people with type 1 diabetes, management burden including suboptimal insulin preparations remains a major barrier to ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with ...

DexCom's revised FY24 sales guidance in the Q2 earnings call led to a $18bn valuation reset. Read why I think DXCM stock is a ...

Time spent above, not below, the target glucose range was associated with mortality in a study of adults with type 2 diabetes ...

The company, which manufactures CGM devices, partnered with Allison PR for a campaign that aimed to spread awareness of life ...